Clear cell carcinoma of ovary in pregnancy

V, Usha; J Swathy, K

Visibility 83 Views
Downloads 44 Downloads
Permissions
DOI 10.18231/2394-2754.2019.0026
CrossMark
Citation

Clear cell carcinoma of ovary in pregnancy

Author Details:

Usha V

K J Swathy ^*

Indian Journal of Obstetrics and Gynecology Research. 6(1):110-112, 2019. | 10.18231/2394-2754.2019.0026

View PDF

Clear cell carcinoma in pregnancy is a rare event, accounts for less than 1%. Here we present a 29year old women who was incidentally diagnosed to have an abdominal mass corresponding to 24 week size on her first trimester visit, Ca 125 was 49, MRI pelvis showed large complex ovarian cyst probably cystic ovarian neoplasm. Patient underwent fertility preserving staging laparotomy. Intraoperative right salphingo-ovariotomy was performed. Histopathology reported as Clear cell carcinoma of ovary. The couple decided to undergo Medical termination of pregnancy after multidisciplinary team counselling provided by Medical oncologist and obstetrician. After six months of adjuvant chemotherapy with paclitaxel and carboplatin patient improved symptomatically better and is on regular follow up.

Keywords: Clear cell carcinoma of ovary.

References

Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long- time follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 1996;78:278–286.
Donnez J, Munschke A, Berliere M, Piarard C, Jadou P, Smets M, Squifflet J. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril 2003;79:1216–1221. K J Swathy et al. Clear cell carcinoma of ovary in pregnancy Indian Journal of Obstetrics and Gynecology Research, January-March, 2019;6(1):110-112 112
Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992;152:573–576.
Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989;16:337–346.
Arango HA, Kalter CS, Decesare SL, Fiorica JV, Lyman GH, Spellacy WN. Management of chemotherapy in a pregnancy complicated by a large neuroblastoma. Obstet Gynecol 1994;84:665–668.
Horbelt D, Delmore J, Meisel R, Cho S, Roberts D, Logan D. Mixed germ cell malignancy of the ovary concurrent with pregnancy. Obstet Gynecol 1994;84:662–664.
Huang HP, Fang CN, Kan YY. Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: a case report. Eur J Gynaecol Oncol 2004;25:635–636.
Bayhan G, Aban M, Yayla M, Gul T, Yaldiz M, Erden AC. Cisplatinum combination chemotherapy during pregnancy for mucinous cystadenocarcinoma of the ovary. Case report. Eur J Gynaecol Oncol 1999;20:231–232.
Mendez LE, Mueller A, Salom E, Gonzalez-Quintero VH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet Gynecol 2003;102:1200–1202.
Sood AK, Shahin MS, Sorosky JI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 2001;83:599–600.
Zhao XY, Huang HF, Lian LJ, Lang JH. Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature. Int J Gynecol Cancer 2006;16:8–15.

Indian Journal of Obstetrics and Gynecology Research

Clear cell carcinoma of ovary in pregnancy

Author Details: Usha V K J Swathy *

References

How to Cite This Article

Vancouver

APA

MLA

Chicago

Author Details:

Usha V

K J Swathy ^*